202 related articles for article (PubMed ID: 16199099)
21. Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient.
Benschop KSM; Wildenbeest JG; Koen G; Minnaar RP; van Hemert FJ; Westerhuis BM; Pajkrt D; van den Broek PJ; Vossen ACTM; Wolthers KC
J Gen Virol; 2015 Mar; 96(Pt 3):571-579. PubMed ID: 25395595
[TBL] [Abstract][Full Text] [Related]
22. Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Choi HJ; Song JH; Lim CH; Baek SH; Kwon DH
J Med Food; 2010 Apr; 13(2):326-8. PubMed ID: 20412019
[TBL] [Abstract][Full Text] [Related]
23. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
[TBL] [Abstract][Full Text] [Related]
25. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK; Olsson A; Korsgren O; Frisk G
Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of a variant rhinovirus from an outbreak associated with uncommonly high mortality.
Kiang D; Yagi S; Kantardjieff KA; Kim EJ; Louie JK; Schnurr DP
J Clin Virol; 2007 Mar; 38(3):227-37. PubMed ID: 17276135
[TBL] [Abstract][Full Text] [Related]
28. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
[TBL] [Abstract][Full Text] [Related]
29. The human rhinovirus internal cis-acting replication element (cre) exhibits disparate properties among serotypes.
McKnight KL
Arch Virol; 2003 Dec; 148(12):2397-418. PubMed ID: 14648294
[TBL] [Abstract][Full Text] [Related]
30. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
31. Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.
Rollinger JM; Steindl TM; Schuster D; Kirchmair J; Anrain K; Ellmerer EP; Langer T; Stuppner H; Wutzler P; Schmidtke M
J Med Chem; 2008 Feb; 51(4):842-51. PubMed ID: 18247552
[TBL] [Abstract][Full Text] [Related]
32. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
[TBL] [Abstract][Full Text] [Related]
33. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
34. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
35. Labeling of capsid proteins and genomic RNA of human rhinovirus with two different fluorescent dyes for selective detection by capillary electrophoresis.
Kremser L; Petsch M; Blaas D; Kenndler E
Anal Chem; 2004 Dec; 76(24):7360-5. PubMed ID: 15595880
[TBL] [Abstract][Full Text] [Related]
36. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
[TBL] [Abstract][Full Text] [Related]
37. Novel species of human rhinoviruses in acute otitis media.
Savolainen-Kopra C; Blomqvist S; Kilpi T; Roivainen M; Hovi T
Pediatr Infect Dis J; 2009 Jan; 28(1):59-61. PubMed ID: 19057460
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
[TBL] [Abstract][Full Text] [Related]
39. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
Pabbaraju K; Ho KC; Wong S; Shokoples S; Pang XL; Fonseca K; Fox JD
Antiviral Res; 2008 Aug; 79(2):81-6. PubMed ID: 18258311
[TBL] [Abstract][Full Text] [Related]
40. Amplicon sequencing and improved detection of human rhinovirus in respiratory samples.
Deffernez C; Wunderli W; Thomas Y; Yerly S; Perrin L; Kaiser L
J Clin Microbiol; 2004 Jul; 42(7):3212-8. PubMed ID: 15243084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
